Fifty-third Board Meeting

Loading...
Date
YYYY-MM-DD
Board Meeting Decision Point Number Title
2025-09-30 B53 GF/B53/EDP12 Appointment of the Vice-Chair of the Ethics and Governance Committee Appointment of the Vice-Chair of the Ethics and Governance Committee
<p>The Board approves the appointment of Jennifer Kates to serve as the Vice-Chair of the Ethics and Governance Committee (the “EGC”), effective from the date of approval of this decision and for a term concurrent with the term of the committee as set out in decision point GF/B52/EDP10 or until the appointment of her successor.</p>
2025-08-06 B53 GF/B53/EDP08 Approval of the Terms of Reference for the Executive Director Nomination Committee Approval of the Terms of Reference for the Executive Director Nomination Committee
<ol> <li>Based on the recommendation of the Chair and Vice-Chair of the Board (the “Board Leadership”), in consultation with the Ethics and Governance Committee (the “EGC”), the Board: <ol type="a"> <li>Notes its responsibilities with regard to the recruitment process of the Executive Director as set out in Article 36 of the Operating Procedures of the Board and Committees of the Global Fund to Fight AIDS, Tuberculosis and Malaria (“BCOP”);</li> <li>Notes the consultations of the Board Leadership and the EGC in relation to this process, including with respect to the establishment of the nomination committee referred to in the BCOP; and</li> <li>Approves the terms of reference of the Executive Director Nomination Committee, as set out in Annex 1 of GF/B53/ER07.</li> </ol> </li> <li>The Board requests the Board Leadership to submit a Chair, Vice-Chair and the membership of the nomination committee to the Board for approval.</li> </ol>
2025-08-04 B53 GF/B53/EDP07 Approval of the Amendments to the Terms of Reference of the Ethics Officer Approval of the Amendments to the Terms of Reference of the Ethics Officer
<p>Based on the recommendation of the Ethics and Governance Committee, the Board:</p> <ol> <li>Approves the Amendments to the Terms of Reference of the Ethics Officer, as set forth in Annex 1 to GF/B53/ER06; and</li> <li>Acknowledges with thanks the service of the incumbent Ethics Officer and her continued support to the mission of the Global Fund through the newly established dual-role.&nbsp;</li> </ol>
2025-07-30 B53 GF/B53/EDP06 Approval of the Report of the 53rd Board Meeting Approval of the Report of the 53rd Board Meeting
<p>The Board approves the Report of the 53rd Board Meeting, as set forth in GF/B53/ER05.</p>
2025-07-18 B53 GF/B53/EDP05 Appointment of Independent Committee Member of the Ethics and Governance Committee Appointment of Independent Committee Member of the Ethics and Governance Committee
<ol> <li>Based on the recommendations of the Board Leadership, the Board approves the appointment of Ms. Sujin Chan-Allen to serve as non-voting independent Member of the Ethics and Governance Committee (the “EGC”),</li> <li>The Board notes that the independent committee member appointed under this decision point shall begin her term at the date of approval of this decision and serve for a term concurrent with the term of the committee as set out in GF/B52/EDP10 or until the appointment of her successor. The independent committee member term is renewable once.</li> </ol>
2025-05-08 B53 GF/B53/DP03 Approval of the Revised Terms of Reference of the Technical Review Panel Approval of the Revised Terms of Reference of the Technical Review Panel
<ol> <li>The Board notes the recommendation of the Strategy Committee as set forth in GF/SC27/EDP01 and approves the revised Terms of Reference of the Technical Review Panel as set forth in Annex 1 to GF/B53/07, which shall have effect as of the date of this decision.</li> </ol>
2025-05-08 B53 GF/B53/DP02 Approval of the Rapporteur Approval of the Rapporteur
<p>Dereck Springer from the Latin America and Caribbean constituency is designated as Rapporteur for the 53rd Board Meeting.</p>
2025-05-08 B53 GF/B53/DP01 Approval of the Agenda Approval of the Agenda
<p>The Agenda for the 53rd Board Meeting (GF/B53/01) is approved.</p>
}